 "Covishield")
NEW DELHI (Reuters) - The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95).
"Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity," it said in a statement. "We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems."
($1 = 75.4620 Indian rupees)
(Reporting by Krishna N. Das and Euan Rocha, editing by Louise Heavens)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
